Department of Urology, MD Anderson Cancer Center, Houston, TX, USA.
Division of Urology, Department of Surgery, Sinai Health System, University of Toronto, Toronto, ON, Canada.
Nat Rev Urol. 2021 Oct;18(10):611-622. doi: 10.1038/s41585-021-00481-1. Epub 2021 Jun 15.
Bacillus Calmette-Guérin (BCG) is the most widely used vaccine worldwide and has been used to prevent tuberculosis for a century. BCG also stimulates an anti-tumour immune response, which urologists have harnessed for the treatment of non-muscle-invasive bladder cancer. A growing body of evidence indicates that BCG offers protection against various non-mycobacterial and viral infections. The non-specific effects of BCG occur via the induction of trained immunity and form the basis for the hypothesis that BCG vaccination could be used to protect against the severity of coronavirus disease 2019 (COVID-19). This Perspective article highlights key milestones in the 100-year history of BCG and projects its potential role in the COVID-19 pandemic.
卡介苗(BCG)是全球应用最广泛的疫苗,已被用于预防结核病一个世纪。BCG 还能刺激抗肿瘤免疫反应,泌尿科医生已将其用于治疗非肌肉浸润性膀胱癌。越来越多的证据表明,BCG 可以预防各种非分枝杆菌和病毒感染。BCG 通过诱导训练有素的免疫产生非特异性作用,这为假设提供了依据,即卡介苗接种可用于预防 2019 年冠状病毒病(COVID-19)的严重程度。本文重点介绍了 BCG 100 年历史中的关键里程碑,并预测了其在 COVID-19 大流行中的潜在作用。
Nat Rev Urol. 2021-10
Lancet Infect Dis. 2022-1
Clin Dermatol. 2021
Urol Oncol. 2021-2
Medicine (Baltimore). 2022-12-2
Am J Med Sci. 2021-6
Perspect Biol Med. 2001
BJU Int. 2013-3-20
Hum Vaccin Immunother. 2025-12
Cancer Res Commun. 2025-6-1
Cell Chem Biol. 2025-5-15
Adv Drug Deliv Rev. 2025-6
Mol Ther. 2025-6-4
N Engl J Med. 2021-2-4
J Clin Invest. 2021-1-19
N Engl J Med. 2020-12-31
J Travel Med. 2020-11-9